We read with interest the article by Clifford and colleagues in HEPATOLOGY.1 This well-designed study identified genetic factors associated with hepatocellular carcinoma (HCC) or liver cirrhosis (LC). Their analysis isolated a single-nucleotide polymorphism (SNP) for the TPTE2 gene, a PTEN (phosphatase and tensin) homolog encoded by chromosome 13, that differentiates HCC and LC.
As for ourselves, we identified sequences near the TPTE2 gene that are replicated in the genome, flawing the interpretation of a genome-wide association study. We have inputted the flanking sequence of the aforementioned SNP rs2880301 (CTTTGCAGCAATCCAG [C/T] CTAAAAGCCTAAAAGC) in the Basic Local Alignment Search Tool (BLAST) from the National Center for Biotechnology Information website. Strikingly, we found total homology with a nucleotide sequence located both on chromosome 13 and the Y chromosome. To rule out that the association found by Clifford et al. was due to a major bias in the sex distribution of the patients affected by HCC or LC, we reanalyzed the raw data. There was a strong disequilibrium of sex between the two disease states: thus, the male/female sex ratio was 3.4 in HCC and 1.3 in LC. We found that the value of SNP rs2880301 was associated with sex rather than with disease status (Fig. 1).
We thus believe that the data from this genome-wide association study does not encourage further study of TPTE2 in these diseases.